Journal of the Neurological Sciences
Volume 208, Issue 1 , Pages 105-108 , 15 April 2003

Statin therapy and small fibre neuropathy: a serial electrophysiological study

  • Y.L. Lo

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +65-63265003; fax: +65-62203321.
    • Department of Neurology, Singapore General Hospital, Outram Road, Singapore 169608, Singapore
    • ,
  • T.H. Leoh

      Affiliations

    • Department of Neurology, Singapore General Hospital, Outram Road, Singapore 169608, Singapore
    • ,
  • L.M. Loh

      Affiliations

    • Department of Endocrinology, Singapore General Hospital, Outram Road, Singapore 169608, Singapore
    • ,
  • C.E. Tan

      Affiliations

    • Department of Endocrinology, Singapore General Hospital, Outram Road, Singapore 169608, Singapore

Received 8 April 2002 ,Revised 8 October 2002 ,Accepted 15 October 2002.

References 

  1. Magnifico F, Misra VP, Murray NM, et al.  The sympathetic skin response in peripheral autonomic failure: evaluation in pure failure, pure cholinergic dysautonomia and dopamine betahydroxylase deficiency. Clin. Auton. Res. 1998;8:133–138
  2. Hay JE, Ttaylor PK, Nukada H. Auditory and inspiratory gasp-evoked sympathetic skin response: age effects. J. Neurol. Sci. 1997;148:19–23
  3. Ozge A, Saracoglu M, Gurtekin Y, et al.  The sensitivity of sympathetic skin responses and standard electrophysiological methods in diagnosis of diabetic neuropathy. Electromyogr. Clin. Neurophysiol. 2000;40:37–43
  4. Braune HJ, Horter C. Sympathetic skin response in diabetic neuropathy: a prospective clinical and neurophysiological trial on 100 patients. J. Neurol. Sci. 1996;138:120–124
  5. Spitzer A, Lang E, Birklein F, et al.  Cardiac autonomic involvement and peripheral nerve function in patients with diabetic neuropathy. Funct. Neurol. 1997;12:115–122
  6. Jeppesen U, Gaist D, Smith T, et al.  Statins and peripheral neuropathy. Eur. J. Clin. Pharmacol. 1999;54:835–838
  7. Gaist D, Garcia Rodriguez LA, Huerta C, et al.  Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?. Eur. J. Clin. Pharmacol. 2001;56:931–933
  8. Igel M, Sudhop T, von Bergmann K. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins). Eur. J. Clin. Pharmacol. 2001;57:357–364
  9. Ziajka PE, Wehmeier T. Peripheral neuropathy and lipid-lowering therapy. South Med. J. 1998;91:667–668
  10. Phan T, McLeod JG, Pollard JD, et al.  J. Neurol. Neurosurg. Psychiatry. 1995;58:625–628
  11. Chazerain P, Hayem G, Hamza S, et al.  Four cases of tendinopathy in patients on statin therapy. Joint Bone Spine. 2001;68:430–433
  12. Shahani BT, Halperin JJ, Boulu P, et al.  Sympathetic skin response: a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J. Neurol. Neurosurg. Psychiatry. 1984;47:536–542
  13. Gutrecht JA. Sympathetic skin response. J. Clin. Neurophysiol. 1994;11:519–524
  14. England JD, Viles A, Walsh JC, et al.  Muscle side effects associated with simvastatin therapy. Med. J. Aust. 1990;153:562–563

PII: S0022-510X(02)00396-9

doi: 10.1016/S0022-510X(02)00396-9

Journal of the Neurological Sciences
Volume 208, Issue 1 , Pages 105-108 , 15 April 2003

Article Tools

* Image Usage & Resolution